The Scripps Research Institute
10550 North Torrey Pines Road
La Jolla
California
92037
United States
Tel: 858-784-1000
Fax: 858-784-8118
Website: http://www.scripps.edu/
291 articles with The Scripps Research Institute
-
MindMed, Scripps Research, Cingulate Therapeutics and the University of Pennsylvania discuss innovative treatments on the horizon for the treatment of anxiety disorder.
-
Aspen Neuroscience closed on a Series B funding round of $147.5 million. The company is focused on developing personalized cell replacements for Parkinson’s disease.
-
Jennifer Rubio, co-founder and CEO of Away, joins the Board of Directors at Scripps Research
3/24/2022
Entrepreneur and philanthropist Jennifer Rubio has been named to the Board of Directors at Scripps Research.
-
New research suggests spider silk may have a use for cancer therapies. For that and more research news, continue reading.
-
Moderna invested heavily in mRNA technology to manufacture some 900 million doses of the COVID-19 vaccine. Now, the company has created an mRNA-based vaccine to prevent HIV.
-
Newpath is guided by the ethos: “Do the right thing and good things will happen."
-
Richard Lerner, who played a significant role in shaping both Scripps Research and the San Diego life sciences ecosystem and developing AbbVie’s blockbuster drug Humira, died Dec. 2.
-
Expansion said much of the funds will go into its SMiRNA platform to find clinical candidates in myotonic DM1, FTD, ALS, and several other tauopathies.
-
Starpharma's Viraleze has reduced the viral load by over 99.9% when it was administered nasally into the trachea and lungs of animals who were positive with the virus, compared to saline control.
-
A New Approach to Curing HIV
8/17/2021
Over the last 40 years, HIV has shifted from a deadly and mysterious virus to one that can be controlled with daily drugs. But attempts to completely eliminate the virus from the bodies of people living with HIV, curing them for good, have failed.
-
Polymers "click" together using green chemistry
8/16/2021
SOF4 is a gas that was discovered over a hundred years ago but is rarely used because it is difficult to prepare and highly reactive.
-
DiosCURE Announces Exclusive Worldwide License Agreement for Best-in-Class Nanobodies Against COVID-19
7/28/2021
DiosCURE Therapeutics SE announced that it has signed an exclusive licensing agreement with the research and invention parties University of Bonn, University Hospital Bonn, Scripps Research and Macrostruct Holding & Consulting AB, for a broad suite of intellectual property, including the single-domain antibodies, DIOS-202, DIOS-203 and DIOS-301, currently in preclinical development as a potential differentiated, highly-efficacious therapy against SARS-CoV-2.
-
There has been a flurry of expansion activity in the life sciences industry as biopharma and diagnostic companies expand manufacturing sites. Here’s a look.
-
Do Therapies for Alzheimer’s & Parkinson’s that Clear Abnormal Brain Proteins Make the Diseases W...
4/2/2021
One of the common research approaches to treating brain diseases such as Parkinson’s disease (PD) and Alzheimer’s disease (AD) is using antibodies designed to clear the accumulated misfolded proteins implicated in the diseases. To date, these drug trials have not been particularly successful at i... -
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
IAVI and Scripps Research Join Efforts with the U.S. National Institutes of Health to Expedite Development of Globally Accessible and Affordable HIV Antibody Combination Products
7/9/2020
Today during the global conference AIDS 2020: Virtual , IAVI, a scientific research organization dedicated to addressing urgent unmet health needs including HIV and tuberculosis, announced an innovative collaboration with Scripps Research and the National Institute of Allergy and Infectious Diseases (N
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Mutated COVID-19 Viral Strain in U.S. and Europe 10 Times More Contagious than Original Strain
6/30/2020
Researchers have found that the strains spreading so quickly in Europe and the U.S. have a mutated S “spike” protein that makes it about 10 times more infectious than the strain that originally was identified in Asia. -
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
San Diego's scientific and medical institutes collaborate on large-scale research program to study spread of COVID-19
6/16/2020
With a focus on screening local healthcare workers and first responders, the epidemiological study seeks to understand the prevalence of coronavirus infections in the community.